Table 2.
Tolerability to exercise training in men with mCRPC
| Variable | N | Pct. (%) |
|---|---|---|
| Permanent discontinuation (from consent) | 6 | 20 |
| Health-related | ||
| Disease progression | 4 | 67 |
| Death | 1 | 17 |
| Personal | ||
| Caring responsibilities | 1 | 17 |
| Exercise interruption | 9 | - |
| Health-related | ||
| Treatment-related | 3 | 33 |
| Infection | 2 | 22 |
| Unwell | 1 | 11 |
| Fracture | 1 | 11 |
| Non-health related | 2 | 22 |
| Mean number of AET sessions completed (of 55) | 51 | 93 |
| Number who completed > 70% AET sessions as or more than prescribed | 20 | 77 |
| Number of AET dose escalations (weeks) | 162 | 56 |
| Number of AET dose reductions (weeks) | 98 | 34 |
| Health-related | ||
| Fatigue | 22 | 22 |
| Bone pain | 30 | 29 |
| Nausea | 5 | 5 |
| Non health-related | ||
| Time constraints / other commitments | 12 | 12 |
| Vacation | 12 | 12 |
| Weather | 7 | 7 |
| Other/no reason | 10 | 10 |
| Mean number of RET sessions completed (of 24 minimum) | 42 | 175 |
| Number who completed > 70% RET sessions as or more than prescribed | 19 | 79 |
N number, Pct percentage, AET aerobic exercise training, RET resistance exercise training